Feng Cheng, China Newswire

Feng Cheng, China Newswire

Comprehensive Real-Time News Feed for Feng Cheng, China.

Results 1 - 3 of 3 in Feng Cheng, China

  1. Wah Sun Gravitates to Cambodia Cost-EfficienciesRead the original story

    Jan 14, 2018 | The Standard

    Janice HuangWah Sun Handbags International Holdings, the world's fifth biggest non-leather handbag original equipment manufacturer in terms of sales revenue, closes subscriptions today for its public float. Trading in its shares on the maiin board begins on January 22.Wah Sun issued 100 million shares at an indicative price range of between HK$1 and HK$1.38 per share, raising up to HK$138 million.... Wah Sun Handbags International Holdings, the world's fifth biggest non-leather handbag original equipment manufacturer in terms of sales revenue, closes subscriptions today for its public float.

    Comment?

  2. FSA 2018 Empowering Asia's Filtration MarketRead the original story w/Photo

    Jan 7, 2018 | PR Newswire

    Abalioglu, Aca, Ahlstrom - Munksjo, Berry Global, Binnova, Bonar High Performance, Boyoo, C & M Filtration, Chongqing Zaisheng, Dejia Filter Machine, Feite, Feng Cheng Machinery, Graham C, Hangzhou Specical Paper, Hengyong, Hollingsworth & Vose, Huachuang, Jcem, Jiaxin, Johns Manvile, Leitai, Lenzing, Libero, Low & Bonar, Ndc, Palas, Pulan, Pulisen Machinery, 11 editions of FILTREX , a conference and exhibition dedicated to the promotion of nonwoven filter media, have been held so far t will be organized by the China Filtration Society , China Nonwovens Technology Association and UBM China, together with EDANA.

    Comment?

  3. OmniComm Systems Signs TrialOne Contract With Beijing Hospital of the Ministry of HealthRead the original story

    Oct 9, 2017 | PressReleasePoint

    Fort Lauderdale, FL - OmniComm Systems, Inc. , a leading provider of clinical data management technology, recently signed a contract with in China to provide its TrialOne clinic automation solution to the hospital's clinical research unit. Beijing Hospital's Phase I unit emphasizes early-phase pharmacology research, and OmniComm's TrialOne system is eminently suited to help the unit achieve its goals.

    Comment?